For Immediate Release | 19 May 2011 |
ImmuPharma PLC
Result of Annual General Meeting
ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.
- End -
For further information please contact:
ImmuPharma PLC:
Dr Robert Zimmer, President & Chief Scientific Officer + 33 389 32 76 50
Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080
Richard Warr, Chairman +44 20 7152 4080
Buchanan Communications
Lisa Baderoon
Mark Court +44 20 7466 5000
Panmure, Gordon & Co., NOMAD & Broker
Andrew Burnett
Rakesh Sharma +44 20 7459 3600
Espirito Santo Investment Bank
James Bromhead
Richard Crawley +44 20 7456 9191